Sleeping sickness incidence for the 36 endemic countries has shown a steady decline in recent years and we should take advantage of the apparent lull in incidence and aim for elimination. This is feasible in some sleeping sickness foci but must be planned and paid for increasingly by the endemic countries themselves. The control and elimination of T. b. gambiense sleeping sickness may be seen as a public good, as appropriate strategies depend on local health services for surveillance and treatment, but public–private funding mechanisms should not be excluded. It is timely to take up the tools available and invest in new tools – including novel financial instruments – to eliminate this disease from Africa.
Welburn, S.C.; Maudlin, I. Priorities for the Elimination of Sleeping Sickness. In: Advances in Parasitology, Volume 79. Elsevier, (2012) 299-337. [DOI: 10.1016/B978-0-12-398457-9.00004-4]